Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)
Clinical trial NCT05091411 · UNKNOWN
Trial details
- NCT number
- NCT05091411
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-09
- Primary completion
- 2021-11-01
- Enrollment
- 1680
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.